337 - 348 of 7723 results
1 CME CREDIT

What's Poppin? Acne and Other Skin Concerns

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

In recent years, many advances have occurred in the medical management of dermatologic disease. What's Poppin? will delve into the diagnosis and management of skin disorders seen commonly in primary care and will discuss updated therapeutic options.


1 CME CREDIT

Panel Discussion: Cases and Controversies in Nephrology

1.00 CME/MOC
1.00 AANP | 0.60 Pharmacology

Nephrology can be a challenging topic for primary care providers. In this panel discussion, nephrologists Rajeev Raghavan, MD and Melanie Hoeing, MD will provide concise practice-changing pearls to help you better manage your patients with kidney disease.


1 CME CREDIT

This talk provides a brief summary of the alternative systems of healing and contrasts them with conventional modern medicine. Current use of Complementary and Alternative Medicine (CAM) in rheumatic diseases is described followed by dietary intervention and the role of the microbiome in rheumatic diseases and the rationale for using probiotics. Current evidence-based findings for CAM in osteoarthritis, rheumatoid arthritis and fibromyalgia are reviewed and the role of platelet-rich plasma injections in treating arthritis.


1 CME CREDIT

This session will provide an overview of the differences in the prevention and screening for select cancers (colon, prostate, breast, and lung) in African Americans. Discussion will focus on differences in the interpretation of common laboratory results including TSH, CBC, and others based on population outcome data.


1 CME CREDIT

Although women make up a majority of the population and typically the majority of primary care providers patient panel, it is well established that many gender specific needs of women, such as menopause and sexual health, are neglected, in part due to lack of women’s health education in these areas. In today’s panel, 3 women’s health experts will discuss 3 women’s health cases that highlight current data and best practice for management of early menopause, GSM, and women known to carry a genetic mutation that elevates their risk of breast and ovarian cancer.


0.5 CME CREDIT

Bone up on normal and abnormal knee anatomy and improve your skill in performing a focused history and physical exam that will help you evaluate knee pain and narrow the differential diagnosis. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on August 26th, 2020 and they are subject to change as new information is published.


0.5 CME CREDIT

In the seventeenth episode of Pri-Med’s weekly web series on COVID-19, faculty will explore how the COVID-19 pandemic has influenced non-communicable diseases and impacted healthcare beyond SARS-CoV-2 infection. Faulty will also discuss the role of masks to reduce the risk of respiratory infections and compare the efficiency of different masks. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 09/01/2020 and they are subject to change as new information is published.


1 CME CREDIT

Over ten percent of the U.S. population suffers disproportionate cardiometabolic risk because of their type 2 diabetes (T2DM). In light of recent data, GLP-1 receptor agonists (GLP-1 RAs) have taken on a more prominent role in T2DM management algorithms. This session will discuss how you can distinguish among GLP-1 RAs and use them in your practice to help manage the risks that these patients face beyond glucose control. A member of the Diabetes Sisters organization will also be joining us to discuss their experience with starting a GLP-1 RA as a patient.


0.5 CME CREDIT

Join us for the final COVID-19 Pulse session of 2020! In the twenty-third episode of Pri-Med’s web series on COVID-19, faculty revisit the discussion of monoclonal antibodies, with a more in-depth look at the recent data and recommendations on monoclonal antibody use in COVID-19. Our learners also continue to have many questions about the relationship between COVID-19 and thrombotic complications. This session will discuss those questions as well as prophylaxis and treatment for venous thromboembolism in patients with COVID-19. Faculty will conclude with a Q&A session to answer your most pressing COVID-19 questions, including those about recent vaccine updates. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/15/2020 and they are subject to change as new information is published.


1.5 CME CREDITS

In the last year, two new diseases have emerged with significant and lasting impact on the lung: E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and COVID-19 pneumonia. This session will address new information and challenges related to both diseases. Vaping has increased in popularity, especially among youth, and in late 2019, EVALI was first described. While the outbreak has subsided, recognition of the symptoms, association with marijuana use, and radiographic findings of EVALI remain important. Further, providing tobacco and marijuana cessation guidance remains critical. The COVID-19 pandemic, caused by SARS-Cov2 virus, has burdened healthcare workers and scientists across the globe. COVID-19, often associated with severe pneumonia and systemic illness, has resulted in significant morbidity and mortality in the US and we can continue to learn and discover its full impact. Additionally, COVID-19 has unmasked major health disparities in our healthcare system that we must address.